Listed Medicine Reforms – Permitted Indications and Application Fees
Permitted Indications The closing date for proposing additional indications or [...]
Third Assessment Pathway for Listed Complementary Medicines
Intermediate Level – Listed Assessed Medicines Reform recommendations for complementary [...]
Labelling Revised – Amendments to the Therapeutic Goods Order No. 92
The four-year transition period for the new labelling requirements (from [...]
Pharmacovigilance Inspection Program
As of 1 September 2017 the TGA’s Pharmacovigilance Inspection Program [...]
Listed Medicine Reforms – Draft List of Permitted Indications
In September 2016, the Government announced that the TGA would [...]
Updates to the Permissible Ingredients Determination for Listed Medicines
An updated version of the Therapeutic Goods (Permissible Ingredients) Determination [...]
New Zealand Natural Products Updated draft Permitted Substances List
An update to the draft Permitted Substances List has been [...]
How to declare $0 turnover through eBS
The opportunity to declare $0 turnover for ARTG entries became [...]
TGA Fee Increase 1 July 2017
Most TGA fees and charges will increase by 1.65% (subject [...]
TGA Annual Charges and Annual Charge Exemption (ACE) Dates
Declarations for annual charge exemptions are due NO LATER THAN: [...]